Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns
Not yet recruiting
- Conditions
- Merkel Cell Carcinoma
- Registration Number
- NCT06039033
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Taking part in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This study will admit a wide range of data on the clinical trial experience of Merkel cell carcinoma patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Merkel cell carcinoma patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Aged ≥ 18 years old
- Able to comprehend the investigational nature of the protocol and provide informed consent
- Diagnosis of Merkel cell carcinoma
Exclusion Criteria
- No diagnosis of Merkel cell carcinoma confirmed
- Inability to perform regular electronic reporting
- Patient does not understand, sign, and return consent form
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of patients who decide to enroll in a Merkel cell carcinoma clinical research 3 months Rate of patients who remain in Merkel cell carcinoma clinical research to trial completion 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States